Arrestin beta 1 Regulates Alveolar Progenitor Renewal and Lung Fibrosis
Journal of Respiratory Biology and Translational Medicine · 2024
DOI: 10.35534/jrbtm.2024.10006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Respiratory Biology and Translational Medicine, 2024. Verfasst von Guanling Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Women's Guild Lung Institute, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIA NIH HHS.
Abstract (Originalsprache)
The molecular mechanisms that regulate progressive pulmonary fibrosis remain poorly understood. Type 2 alveolar epithelial cells (AEC2s) function as adult stem cells in the lung. We previously showed that there is a loss of AEC2s and a failure of AEC2 renewal in the lungs of idiopathic pulmonary fibrosis (IPF) patients. We also reported that beta-arrestins are the key regulators of fibroblast invasion, and beta-arrestin 1 and 2 deficient mice exhibit decreased mortality, decreased matrix deposition, and increased lung function in bleomycin-induced lung fibrosis. However, the role of beta-arrestins in AEC2 regeneration is unclear. In this study, we investigated the role and mechanism of Arrestin beta 1 (ARRB1) in AEC2 renewal and in lung fibrosis. We used conventional deletion as well as cell type-specific deletion of ARRB1 in mice and found that Arrb1 deficiency in fibroblasts protects mice from lung fibrosis, and the knockout mice exhibit enhanced AEC2 regeneration in vivo, suggesting a role of fibroblast-derived ARRB1 in AEC2 renewal. We further found that Arrb1-deficient fibroblasts promotes AEC2 renewal in 3D organoid assays. Mechanistically, we found that CCL7 is among the top downregulated cytokines in Arrb1 deficient fibroblasts and CCL7 inhibits AEC2 regeneration in 3D organoid experiments. Therefore, fibroblast ARRB1 mediates AEC2 renewal, possibly by releasing chemokine CCL7, leading to fibrosis in the lung.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pulmonary, Women's Guild Lung Institute, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
- Current Address: GH, Sanofi, 500 Kendall Street, Cambridge, MA 02142, USA.
- Current Address: YG, Jiangnan University, 1800 Lihu Avenue, Wuxi, Jiangsu, 214122, China.
- Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Förderung
- NHLBI NIH HHS
- NIA NIH HHS
Zitieren
APA
Huang, G., Geng, Y., Kulur, V., Liu, N., Liu, X., Taghavifar, F., Liang, J., Noble, P. W., & Jiang, D. (2024). Arrestin beta 1 Regulates Alveolar Progenitor Renewal and Lung Fibrosis. Journal of Respiratory Biology and Translational Medicine. https://doi.org/10.35534/jrbtm.2024.10006
Vancouver
Huang G, Geng Y, Kulur V, Liu N, Liu X, Taghavifar F, et al. Arrestin beta 1 Regulates Alveolar Progenitor Renewal and Lung Fibrosis. Journal of Respiratory Biology and Translational Medicine. 2024. doi:10.35534/jrbtm.2024.10006
BibTeX
@article{Huang2024,
author = {Huang, Guanling and Geng, Yan and Kulur, Vrishika and Liu, Ningshan and Liu, Xue and Taghavifar, Forough and Liang, Jiurong and Noble, Paul W and Jiang, Dianhua},
title = {Arrestin beta 1 Regulates Alveolar Progenitor Renewal and Lung Fibrosis},
journal = {Journal of Respiratory Biology and Translational Medicine},
year = {2024},
doi = {10.35534/jrbtm.2024.10006}
}
EUVIMED